NCT03871127已完成不适用
Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis: PRE-COMBAT Trial
Seung-Jung Park9 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2019年5月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 600
- 试验地点
- 9
- 主要终点
- Composite outcome
研究概览
简要总结
This study evaluates Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis(PRECOMBAT trial).
详细描述
This study is an extended one of PRECOMBAT trial.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject group enrolled in PRECOMBAT trial
排除标准
- 未提供
结局指标
主要结局
Composite outcome
时间窗: 10 year
The composite of death, myocardial infarction, and revascularization. Patients who have experienced any one of the following events are considered to have experienced the composite outcome: death, myocardial infarction, and revascularization
次要结局
- Graft reocclusion rate(10 year)
- Graft patency rate(10 year)
- Binary restenosis in both in-stent and in-segment(10 year)
- All-cause mortality(10 year)
- Cardiac death(10 year)
- Cerebrovascular accident(10 year)
- Target vessel revascularization(10 year)
- Target lesion revascularization(10 year)
- Myocardial infarction(10 year)
- Stent thrombosis(10 year)
研究者
Seung-Jung Park
Professor, Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine
Asan Medical Center
研究点 (9)
Loading locations...
相似试验
尚未招募
不适用
Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting Stent Trial: Extended Follow-up StudyCoronary Artery DiseaseJPRN-UMIN000030732Research Institute for Production Development3,196
终止
不适用
Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery LesionsCoronary AtherosclerosisNCT00606333Cordis Corporation394
已完成
4 期
The REALITY Study - Head-to-Head Comparison Between Cypher and TaxusCoronary Artery DiseaseNCT00235092Cordis US Corp.1,335
终止
3 期
A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney TransplantEnd-Stage Renal DiseaseKidney TransplantationNCT00005113Boston Children's Hospital102
已完成
4 期
Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney TransplantKidney TransplantationNCT00188955University of Manitoba40